Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.
Saved in:
| Title: | Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder. |
|---|---|
| Authors: | Stringer KL; Social Intervention Group, Columbia University, NY, New York, United States of America; The Lifespan/Brown Criminal Justice Research Training Program on Substance Use, HIV, and Comorbidities, Center for Prisoner Health and Human Rights, Brown University, United States of America. Electronic address: ks3592@columbia.edu., Langdon KJ; Department of Psychiatry, Rhode Island Hospital, United States of America., McKenzie M; The Miriam Hospital/Brown Alpert Medical School, United States of America., Brockmann B; Dept. of Health Services, Policy and Practice, Brown University School of Public Health, United States of America., Marotta P; The Lifespan/Brown Criminal Justice Research Training Program on Substance Use, HIV, and Comorbidities, Center for Prisoner Health and Human Rights, Brown University, United States of America; Washington University in St. Louis, United States of America. |
| Source: | Journal of substance abuse treatment [J Subst Abuse Treat] 2021 Apr; Vol. 123, pp. 108263. Date of Electronic Publication: 2020 Dec 26. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Pergamon Press Country of Publication: United States NLM ID: 8500909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6483 (Electronic) Linking ISSN: 07405472 NLM ISO Abbreviation: J Subst Abuse Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
